PL414903A1 - Pharmaceutical composition containing combination of vitamin K1, K2 and D3 and its application - Google Patents
Pharmaceutical composition containing combination of vitamin K1, K2 and D3 and its applicationInfo
- Publication number
- PL414903A1 PL414903A1 PL414903A PL41490315A PL414903A1 PL 414903 A1 PL414903 A1 PL 414903A1 PL 414903 A PL414903 A PL 414903A PL 41490315 A PL41490315 A PL 41490315A PL 414903 A1 PL414903 A1 PL 414903A1
- Authority
- PL
- Poland
- Prior art keywords
- vitamin
- application
- pharmaceutical composition
- composition containing
- containing combination
- Prior art date
Links
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 title abstract 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title abstract 3
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 title abstract 3
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 title abstract 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 title abstract 3
- 235000019175 phylloquinone Nutrition 0.000 title abstract 3
- 239000011772 phylloquinone Substances 0.000 title abstract 3
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 title abstract 3
- 229960001898 phytomenadione Drugs 0.000 title abstract 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title abstract 3
- 235000005282 vitamin D3 Nutrition 0.000 title abstract 3
- 239000011647 vitamin D3 Substances 0.000 title abstract 3
- 235000019143 vitamin K2 Nutrition 0.000 title abstract 3
- 239000011728 vitamin K2 Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 230000033558 biomineral tissue development Effects 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 208000007442 rickets Diseases 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem zgłoszenia jest kompozycja farmaceutyczna, zawierająca witaminę K1, K2 i D3, gdzie witamina K1 występuje w ilości 100 µg - 300 µg, witamina K2 występuje w ilości 10 µg - 45 µg, a witamina D3 w ilości 400 IU (10 µg) - 1200 IU (30 µg) oraz jej zastosowanie w celu profilaktyki krwawień, profilaktyki krzywicy oraz zapewnienia prawidłowej mineralizacji tkanki kostnej u niemowląt.The subject of the application is a pharmaceutical composition containing vitamin K1, K2 and D3, where vitamin K1 is in the amount of 100 µg - 300 µg, vitamin K2 is in the amount of 10 µg - 45 µg, and vitamin D3 in the amount of 400 IU (10 µg) - 1200 IU (30 µg) and its use for the prevention of bleeding, prevention of rickets and ensuring the correct mineralization of bone tissue in infants.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL414903A PL414903A1 (en) | 2015-11-23 | 2015-11-23 | Pharmaceutical composition containing combination of vitamin K1, K2 and D3 and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL414903A PL414903A1 (en) | 2015-11-23 | 2015-11-23 | Pharmaceutical composition containing combination of vitamin K1, K2 and D3 and its application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL414903A1 true PL414903A1 (en) | 2017-06-05 |
Family
ID=58793712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL414903A PL414903A1 (en) | 2015-11-23 | 2015-11-23 | Pharmaceutical composition containing combination of vitamin K1, K2 and D3 and its application |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL414903A1 (en) |
-
2015
- 2015-11-23 PL PL414903A patent/PL414903A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021001091A (en) | Methods for treatng huntington's disease. | |
| MX2017008698A (en) | MULTI-SUPPLEMENT COMPOSITIONS. | |
| GEAP202114943A (en) | Aromatic sulfonamide derivatives | |
| MX2018002990A (en) | USE OF PASTEURIZED AKKERMANSIA TO TREAT METABOLIC DISORDERS. | |
| BR112017018368A2 (en) | rna-containing compositions for the treatment of tumoral diseases | |
| EA201991447A1 (en) | VISCOSITY REDUCTION OF PHARMACEUTICAL COMPOSITIONS | |
| MX2019003363A (en) | Pharmaceutical compositions for use in the therapy of blepharitis. | |
| MX2020011104A (en) | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE. | |
| ZA201805792B (en) | Taurine and aloe synergistic anti-irritant compositions and methods | |
| CL2017003066A1 (en) | Compositions of amorphous calcium carbonate for administration by inhalation, sublingual or buccal | |
| BR112016013194A2 (en) | ORAL HYGIENE COMPOSITIONS COMPRISING CALCIUM CARBONATE AND SILICA | |
| MX2018002546A (en) | COMPOSITIONS THAT INCLUDE A UROLITINE COMPOUND. | |
| MX390493B (en) | Compositions comprising mesenchymal stem cells and uses thereof | |
| BR112016024176A2 (en) | oral care compositions having improved stability | |
| MX2018004220A (en) | Pyrazolyl substituted tetrahydropyranylsulfones. | |
| MX2020003049A (en) | SEMAGLUTIDE IN MEDICAL THERAPY. | |
| BR112016019201A2 (en) | solid oral care compositions, teeth cleaning method and use of polyethylene oxide | |
| GEP20186908B (en) | P-substituted asymmetric ureas and medical uses thereof | |
| GEP20237486B (en) | Formulations of copanlisib | |
| CR20190026A (en) | Vaginal composition comprising a combination of estrogen and vitamin d | |
| BR112018007004A2 (en) | pyrazolyl-substituted tetrahydropyransulfones | |
| MX2020007894A (en) | Surface-reacted calcium carbonate for modifying the biomechanical properties of the skin. | |
| PL414902A1 (en) | Pharmaceutical composition containing combination of vitamin K1 and K2 and its application | |
| PH12020550104A1 (en) | Salts of (r)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one | |
| PL414903A1 (en) | Pharmaceutical composition containing combination of vitamin K1, K2 and D3 and its application |